The CARING Study: Creating and Restoring Health Through Nutrition Guidance

Sponsor
Physicians Committee for Responsible Medicine (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05795439
Collaborator
Blue Cross Blue Shield (Other)
700
2
45

Study Details

Study Description

Brief Summary

The CARING study assesses the health benefits of nutrition education for Blue Cross Blue Shield subscribers, as well as potential healthcare cost savings to subscribers and the insurance company.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Low-fat, vegan diet
N/A

Detailed Description

Among Blue Cross Blue Shield subscribers, individuals with type 2 diabetes will be randomly selected and invited to participate in an interventional trial. A control group matched for relevant variables will be selected from Blue Cross Blue Shield subscribers.

The Intervention group participants will be asked to attend weekly online classes on nutrition and health and to follow a low-fat, vegan diet for 16 weeks. Body weight, plasma lipids, HbA1C, dietary intake and adherence, and food acceptability will be assessed at baseline and at 16 weeks. Their longer-term medical utilization will then be tracked and compared with that of a control population selected from Blue Cross Blue Shield subscribers.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
700 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
One arm, the intervention group, will be randomly assigned to be on a low-fat vegan diet for the duration of the study. The other arm, the control group, will maintain their pre-study diet for the duration of the study.One arm, the intervention group, will be randomly assigned to be on a low-fat vegan diet for the duration of the study. The other arm, the control group, will maintain their pre-study diet for the duration of the study.
Masking:
Single (Investigator)
Masking Description:
The control group will be asked to stay on their usual diet.
Primary Purpose:
Treatment
Official Title:
The CARING Study: Creating and Restoring Health Through Nutrition Guidance
Anticipated Study Start Date :
Mar 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2026
Anticipated Study Completion Date :
Dec 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention Group

The Intervention group arm of participants will be asked to attend weekly online classes on nutrition and health and to follow a low-fat, vegan diet for 16 weeks.

Behavioral: Low-fat, vegan diet
The intervention diet consists of whole grains, vegetables, legumes, and fruits, with no restriction on energy intake. Participants will also be guided to favor foods with a low glycemic index. Animal products and added oils will be excluded. The diet is designed to derive approximately 10% of energy from fat, approximately 10-15% of energy from protein, and the remainder from mostly complex carbohydrates. The diet will also provide approximately 40 g of fiber per day.

No Intervention: Control Group

The Control group arm of participants will be asked to maintain their regular, pre-study diet.

Outcome Measures

Primary Outcome Measures

  1. Medical Utilization [16 weeks]

    This study will assess the effectiveness of a series of plant-based nutrition classes on health changes, measured by combined subscriber and insurance total cost of care (healthcare and health benefits).

  2. Body Weight [16 weeks]

    This study will assess the association of attending a series of plant-based nutrition classes with pre-post changes in body weight.

  3. Plasma Lipid Concentrations [16 weeks]

    This study will assess the association of attending a series of plant-based nutrition classes with pre-post changes in plasma lipid concentrations.

  4. HbA1C [16 weeks]

    This study will assess the association of attending a series of plant-based nutrition classes on with pre-post changes in glycemic control in individuals with type 2 diabetes as assessed by hemoglobic A1c (HbA1c) and use of medications.

Secondary Outcome Measures

  1. Diet Acceptability [16 weeks]

    In addition, this study will assess the impact of association of attending a series of plant-based nutrition classes on pre-post changes in diet acceptability. Diet acceptability will be determined using the Food Acceptability Questionnaire (FAQ), asking participants to think about foods they have consumed in the prior two weeks to taking the FAQ, where higher scores indicate greater acceptability. There are eleven questions ranking answers on a scale of 1-7, and one question ranking answers on a scale from 1-13.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Blue Cross Blue Shield subscriber continuously enrolled for the prior 12 months

  2. Male or female

  3. Age at least 18 years

  4. Have a diagnosis of type 2 diabetes

  5. Ability and willingness to participate in all components of the study, including:

  6. Following a plant-based diet for the initial 16 weeks of the study;

  7. Attending weekly online classes for the initial 16 weeks of the study; and

  8. Keeping physical activity level consistent throughout the initial 16 weeks of the study.

Exclusion Criteria:
  1. Diabetes mellitus type 1 or history of any endocrine condition that would affect body weight, such as a pituitary abnormality or Cushing's syndrome

  2. Smoking during the past six months

  3. Alcohol consumption of more than 2 drinks per day or the equivalent, episodic increased drinking (e.g., more than 2 drinks per day on weekends), or a history of alcohol abuse or dependency followed by any current use

  4. Current or unresolved past drug abuse

  5. Recently gave birth, pregnant, or plans to become pregnant before or during the study period

  6. Unstable medical or psychiatric status

  7. Cancer diagnosis

  8. Chronic kidney disease, stage 4 or 5

  9. Evidence of an eating disorder

  10. Lack of English fluency

  11. Bariatric surgery in the last 6 months

  12. Dementia

  13. Institutional custodial care

  14. End of life

  15. Palliative Care

  16. Actively engaged in specific BCBSM diabetes programs and case management programs

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Physicians Committee for Responsible Medicine
  • Blue Cross Blue Shield

Investigators

  • Principal Investigator: Neal Barnard, MD, Physicians Committee for Responsible Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Physicians Committee for Responsible Medicine
ClinicalTrials.gov Identifier:
NCT05795439
Other Study ID Numbers:
  • Pro00069695
First Posted:
Apr 3, 2023
Last Update Posted:
Apr 3, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Physicians Committee for Responsible Medicine
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 3, 2023